Department of Molecular and Cellular Pharmacology, Graduate School of Pharmaceutical Sciences (T.O., E.S., Y.S., H.Y., Y.I.) and Nanomaterial Toxicology Project (H.T.), Nagoya City University, Nagoya, Japan; and Department of Pharmacology, Division of Pathological Sciences, Kyoto Pharmaceutical University, Kyoto, Japan (S.O.)

Department of Molecular and Cellular Pharmacology, Graduate School of Pharmaceutical Sciences (T.O., E.S., Y.S., H.Y., Y.I.) and Nanomaterial Toxicology Project (H.T.), Nagoya City University, Nagoya, Japan; and Department of Pharmacology, Division of Pathological Sciences, Kyoto Pharmaceutical University, Kyoto, Japan (S.O.)

Department of Molecular and Cellular Pharmacology, Graduate School of Pharmaceutical Sciences (T.O., E.S., Y.S., H.Y., Y.I.) and Nanomaterial Toxicology Project (H.T.), Nagoya City University, Nagoya, Japan; and Department of Pharmacology, Division of Pathological Sciences, Kyoto Pharmaceutical University, Kyoto, Japan (S.O.)

Department of Molecular and Cellular Pharmacology, Graduate School of Pharmaceutical Sciences (T.O., E.S., Y.S., H.Y., Y.I.) and Nanomaterial Toxicology Project (H.T.), Nagoya City University, Nagoya, Japan; and Department of Pharmacology, Division of Pathological Sciences, Kyoto Pharmaceutical University, Kyoto, Japan (S.O.)

Department of Molecular and Cellular Pharmacology, Graduate School of Pharmaceutical Sciences (T.O., E.S., Y.S., H.Y., Y.I.) and Nanomaterial Toxicology Project (H.T.), Nagoya City University, Nagoya, Japan; and Department of Pharmacology, Division of Pathological Sciences, Kyoto Pharmaceutical University, Kyoto, Japan (S.O.)

Department of Molecular and Cellular Pharmacology, Graduate School of Pharmaceutical Sciences (T.O., E.S., Y.S., H.Y., Y.I.) and Nanomaterial Toxicology Project (H.T.), Nagoya City University, Nagoya, Japan; and Department of Pharmacology, Division of Pathological Sciences, Kyoto Pharmaceutical University, Kyoto, Japan (S.O.)

Department of Molecular and Cellular Pharmacology, Graduate School of Pharmaceutical Sciences (T.O., E.S., Y.S., H.Y., Y.I.) and Nanomaterial Toxicology Project (H.T.), Nagoya City University, Nagoya, Japan; and Department of Pharmacology, Division of Pathological Sciences, Kyoto Pharmaceutical University, Kyoto, Japan (S.O.)